Sylvia Ai1, Corrina Cliffe2, Giselle Kidson-Gerber1,3. 1. Department of Haematology, NSW Health Pathology, Randwick, Australia. 2. Department of Molecular Genetics, NSW Health Pathology, Randwick, Australia. 3. ■, University of NSW, Kensington, Australia.
Abstract
BACKGROUND: Antenatal screening is vital to identifying couples at risk of having children with a clinically significant haemoglobinopathy. In Australia, immigration is increasing carrier incidence. METHODS: A retrospective analysis was performed of full blood count, high-performance liquid chromatography and haemoglobin electrophoresis of women and their partners who underwent antenatal haemoglobinopathy screening over three years at a major NSW laboratory. Genetic testing results were included where available. RESULTS: One thousand six hundred and twenty-eight women and 729 male partners were screened at a median gestation of 14 weeks. 8.2% of women had a clinically significant result, with a median 16-day interval to partner testing. In 35% of couples screened simultaneously, the partner did not require testing. Genetic confirmatory testing was performed in 65% of high risk couples. CONCLUSION: There was a significant delay to antenatal haemoglobinopathy screening for mothers, limiting time for genetic diagnosis, prenatal diagnosis and management of affected pregnancies. Screening should be performed earlier. Simultaneous couple testing is not cost-effective.
BACKGROUND: Antenatal screening is vital to identifying couples at risk of having children with a clinically significant haemoglobinopathy. In Australia, immigration is increasing carrier incidence. METHODS: A retrospective analysis was performed of full blood count, high-performance liquid chromatography and haemoglobin electrophoresis of women and their partners who underwent antenatal haemoglobinopathy screening over three years at a major NSW laboratory. Genetic testing results were included where available. RESULTS: One thousand six hundred and twenty-eight women and 729 male partners were screened at a median gestation of 14 weeks. 8.2% of women had a clinically significant result, with a median 16-day interval to partner testing. In 35% of couples screened simultaneously, the partner did not require testing. Genetic confirmatory testing was performed in 65% of high risk couples. CONCLUSION: There was a significant delay to antenatal haemoglobinopathy screening for mothers, limiting time for genetic diagnosis, prenatal diagnosis and management of affected pregnancies. Screening should be performed earlier. Simultaneous couple testing is not cost-effective.
Authors: Elizabeth Dormandy; Martin C Gulliford; Erin P Reid; Katrina Brown; Theresa M Marteau Journal: Br J Gen Pract Date: 2008-03 Impact factor: 5.386
Authors: Elizabeth Argent; Phillip Emder; Paul Monagle; David Mowat; Toni Petterson; Susan Russell; Rani Sachdev; Christine Stone; David S Ziegler Journal: J Paediatr Child Health Date: 2011-12-13 Impact factor: 1.954
Authors: E Dormandy; S Bryan; M C Gulliford; T E Roberts; A E Ades; M Calnan; K Atkin; J Karnon; P M Barton; J Logan; F Kavalier; H J Harris; T A Johnston; E N Anionwu; V Davis; K Brown; A Juarez-Garcia; V Tsianakas; T M Marteau Journal: Health Technol Assess Date: 2010-04 Impact factor: 4.014
Authors: Joanne Traeger-Synodinos; Cornelis L Harteveld; John M Old; Mary Petrou; Renzo Galanello; Piero Giordano; Michael Angastioniotis; Barbara De la Salle; Shirley Henderson; Alison May Journal: Eur J Hum Genet Date: 2014-07-23 Impact factor: 4.246